HOME
KOREAN
About Us
Company Overview
BOD and SAB
History
Contact us
R&D
Core Technology
Products
Services
Investor Relations
Stock Price Information
Investor Updates
Media
Notices
Press Release
PR Video
Careers
We're Recruiting
Careers Guide
Antibody Therapeutics for Life
Notices
Press Release
PR Video
Press Release
No
Title
Written by
Written date
Inquire
11
PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS PharmAbcineLogo (PRNewsfoto/PharmAbcine)
PharmAbcine
2020-08-20
3,284
10
PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC
PharmAbcine
2020-08-20
376
9
PharmAbcine to Present Preclinical Data of Blood Vessel Stabilizing PMC-402 at 2020 AACR Meeting
PharmAbcine
2020-05-20
19,376
8
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
PharmAbcine
2020-04-07
16,478
7
PharmAbcine, Announces Acceptance of Phase Ib Olinvacimab and Pembrolizuamb Combination Trial in rGBM Patients Abstract at the 2020 ASCO Annual Meeting
PharmAbcine
2020-04-06
21,298
6
PharmAbcine, Olinvacimb, able to manage the first recruitment of patients for phase II clinical trial
PharmAbcine
2019-11-20
17,930
5
PharmAbcine,BioPharma Dealmakers_sep 2019
PharmAbcine
2019-10-01
15,715
4
PharmAbcine, Drug Discovery Special APAC 2019
PharmAbcine
2019-09-17
19,931
3
PharmAbcine, HREC Approval announcement Austin Health
PharmAbcine
2019-08-23
19,947
2
PharmAbcine Appoints Legendary Pathologist Dr. David Cheresh to Scientific Advisory Board
Admin
2019-03-07
34,329
1
2
3
--Search--
Title
Written by
content